Info: Read More
  • 中药标准品生产商,产品定制服务
  • (20R)-原人参二醇

    (20R)-Protopanaxdiol

    (20R)-原人参二醇
    产品编号 CFN99979
    CAS编号 7755-01-3
    分子式 = 分子量 C30H52O3 = 460.74
    产品纯度 >=98%
    物理属性 White powder
    化合物类型 Triterpenoids
    植物来源 The roots of Panax ginseng C. A. Mey.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    (20R)-原人参二醇 CFN99979 7755-01-3 10mg QQ客服:1457312923
    (20R)-原人参二醇 CFN99979 7755-01-3 20mg QQ客服:1457312923
    (20R)-原人参二醇 CFN99979 7755-01-3 50mg QQ客服:1457312923
    (20R)-原人参二醇 CFN99979 7755-01-3 100mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • National Cancer Institute (USA)
  • University of Toulouse (France)
  • Kazusa DNA Research Institute (Japan)
  • Complutense University of Madrid (Spain)
  • Heinrich-Heine-University Düsseldorf (Germany)
  • Universite de Lille1 (France)
  • University of Bordeaux (France)
  • Instytut Nawozów Sztucznych w Pu?awach (Poland)
  • Medical University of Gdansk (Poland)
  • Yale University (USA)
  • Sapienza University of Rome (Italy)
  • University of Sao Paulo (Brazil)
  • Fraunhofer-Institut für Molekularbiologie und Angewandte ?kologie IME (Germany)
  • University of Amsterdam (Netherlands)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Front Pharmacol.2018, 9:756
  • World J Mens Health.2019, 10.5534
  • Phytomedicine.2021, 93:153796.
  • Food Chem.2024, 436:137768.
  • Research Square2024, rs-4398438
  • J Pharm Pharmacol.2023, 75(9):1225-1236.
  • Bioorg Med Chem.2020, 28(12):115553.
  • Life Sci.2018, 209:498-506
  • Appl. Sci.2020, 10,1304
  • Asian Journal of Chemistry2014, 26(8):2425
  • Internoational J of Toxicology2020, 10.1177.
  • Foods.2021, 10(11):2627.
  • Evid Based Complement Alternat Med.2017, 2017:9764843
  • Nutr Cancer.2024, 76(3):305-315.
  • Food Chem.2023, 424:136383.
  • Research Square2021, 10.21203.
  • Molecules2022, 27(14),4462
  • Asian Pac J Tropical Bio.2020, 10(6):239-247
  • Kaohsiung J Med Sci.2024, 40(3):280-290.
  • Pharmaceuticals (Basel).2021, 14(6):588.
  • J Pharm Biomed Anal2016, 118:183-194
  • Sci Rep.2018, 8(1):12970
  • Evid Based Complement Alternat Med.2020, 2020:2584783.
  • ...
  • 生物活性
    Description: Protopanaxdiol is effective in preventing and healing obesity, fatty liver and hypertriglyceridemia in mice fed with a high-fat diet, it inhibits tumor interstitial microvascular density and its proliferation activity, finally inhibits tumor growth, it also inhibits expression of VEGF and bFGF protein. (20R)-Protopanaxdiol has protective effect on myocardial ischemia, which may be related to improving free radicals metabolism and myocardial metabolism, decreasing plasma TXA 2 levels.
    Targets: p38MAPK | JNK | VEGFR | bFGF | ATF2
    In vitro:
    Fitoterapia. 2010 Dec;81(8):1079-87.
    Anti-Obesity effects of protopanaxdiol types of Ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet.[Pubmed: 20627120]
    Effects of protopanaxdiol (PDG) and protopanaxatriol (PTG) types of ginsenosides isolated from the leaves of American ginseng on porcine pancreatic lipase activity were determined in vitro.
    METHODS AND RESULTS:
    PDG inhibited the pancreatic lipase activity in a dose-dependent manner at the concentrations of 0.25-1mg/ml. It inhibited hydrolysis of about 83.2% of triolein at about 1mg/ml of PDG. However, PTG showed no inhibitory activity. Therefore, anti-obesity activity of PDG was evaluated in mice fed a high-fat diet.
    CONCLUSIONS:
    The results demonstrated that PDG was effective in preventing and healing obesity, fatty liver and hypertriglyceridemia in mice fed with a high-fat diet.
    In vivo:
    J Ginseng Res. 2015 Jan;39(1):61-8
    Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions.[Pubmed: 25535478]
    Korean Red Ginseng (KRG) is a representative traditional herbal medicine with many different pharmacological properties including anticancer, anti-atherosclerosis, anti-diabetes, and anti-inflammatory activities. Only a few studies have explored the molecular mechanism of KRG-mediated anti-inflammatory activity.
    METHODS AND RESULTS:
    We investigated the anti-inflammatory mechanisms of the protopanaxadiol saponin fraction (PPD-SF) of KRG using in vitro and in vivo inflammatory models. PPD-SF dose-dependently diminished the release of inflammatory mediators [nitric oxide (NO), tumor necrosis factor-α, and prostaglandin E2], and downregulated the mRNA expression of their corresponding genes (inducible NO synthase, tumor necrosis factor-α, and cyclooxygenase-2), without altering cell viability. The PPD-SF-mediated suppression of these events appeared to be regulated by a blockade of p38, c-Jun N-terminal kinase (JNK), and TANK (TRAF family member-associated NF-kappa-B activator)-binding kinase 1 (TBK1), which are linked to the activation of activating transcription factor 2 (ATF2) and interferon regulatory transcription factor 3 (IRF3). Moreover, this fraction also ameliorated HCl/ethanol/-induced gastritis via suppression of phospho-JNK2 levels.
    CONCLUSIONS:
    These results strongly suggest that the anti-inflammatory action of PPD-SF could be mediated by a reduction in the activation of p38-, JNK2-, and TANK-binding-kinase-1-linked pathways and their corresponding transcription factors (ATF2 and IRF3).
    Journal of Chinese Pharmaceutical Sciences, 2002, 37(2):100-3.
    Antimyocardial ischemic effects of Panax quinquefolium 20s-protopanaxdiol saponins (PQDS) and its mechanism[Reference: WebLink]
    To study the antimyocardial ischemic effects of Panax quinquefolium 20 s-protopanaxdiolsaponins (PQDS) extracted from the leaves of Panax quinquefolium and its mechanism.
    METHODS AND RESULTS:
    The changes of myocardial infarct size, the serum creatine phosphokinase(CK), lactate dehydrogenase (LDH), superoside dismutase(SOD), catalase(CAT) and glutathione peroxidase(GSH-Px) activity, the serum lipid peroxidation(LPO) and myocardial free fatty acid(FFA), lactic acid(LA) content and plasma prostacycline(PGI2) and thromboxane (TXA2) level were determined in rats with acute myocardial infarct model induced by ligating the left anterior descending coronary artery(LAD). After treated by PQDS(in a dosage of 12.5~50 mg · kg-1 iv at the same time of operation and 6 h later), the sizes of acute myocardial infarction were significantly reduced. The serum CK, LDH activity, the plasma TXA2 levels and myocardial FFA and LA contents were declined, while PGI2/TXA2 was increased significantly. In addition, serum LPO content was declined, SOD, CAT and GSH-Px levels were increased markedly.
    CONCLUSIONS:
    PQDS had protective effect on myocardial ischemia, which may be related to improving free radicals metabolism and myocardial metabolism, decreasing plasma TXA2 levels. Therefore, PQDS may be an effective drug for the treatment of myocardial ischemia.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.1704 mL 10.8521 mL 21.7042 mL 43.4084 mL 54.2605 mL
    5 mM 0.4341 mL 2.1704 mL 4.3408 mL 8.6817 mL 10.8521 mL
    10 mM 0.217 mL 1.0852 mL 2.1704 mL 4.3408 mL 5.4261 mL
    50 mM 0.0434 mL 0.217 mL 0.4341 mL 0.8682 mL 1.0852 mL
    100 mM 0.0217 mL 0.1085 mL 0.217 mL 0.4341 mL 0.5426 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    25-甲氧基人参皂苷Rg3; 25-Methoxyginsenoside Rg3 CFN95748 2977279-15-3 C43H76O14 = 817.1 5mg QQ客服:2056216494
    20-甲氧基人参皂苷Rg3; 20-Methoxyginsenoside Rg3 CFN95763 N/A C43H74O13 = 799.1 10mg QQ客服:1457312923
    人参皂苷Rs3; Ginsenoside Rs3 CFN92813 194861-70-6 C44H74O14 = 827.1 5mg QQ客服:2159513211
    三七皂苷Ft1; Notoginsenoside Ft1 CFN90859 155683-00-4 C47H80O17 = 917.2 20mg QQ客服:1457312923
    绞股蓝皂苷LI; Gypenoside LI CFN91853 94987-10-7 C42H72O14 = 801.0 5mg QQ客服:1457312923
    绞股蓝皂苷L; Gypenoside L CFN91854 94987-09-4 C42H72O14 = 801.0 5mg QQ客服:215959384
    20(S)-原人参二醇; (20S)-Protopanaxdiol CFN99764 30636-90-9 C30H52O3 = 460.00 20mg QQ客服:1413575084
    20(S)-人参皂苷Rh2; 20(S)-Ginsenoside Rh2 CFN99971 78214-33-2 C36H62O8 = 622.87 20mg QQ客服:1413575084
    20(R)-人参皂苷Rh2; 20(R)-Ginsenoside Rh2 CFN90340 112246-15-8 C36H62O8 = 622.88 20mg QQ客服:1457312923
    12-甲氧基人参皂苷Rh2; 12-Methoxyginsenoside Rh2 CFN95749 N/A C37H64O9 = 652.9 10mg QQ客服:3257982914

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产